Basilea Pharmaceutica Correlations
| BPMUF Stock | USD 52.83 0.00 0.00% |
The current 90-days correlation between Basilea Pharmaceutica and Protalix Biotherapeutics is -0.08 (i.e., Good diversification). The correlation of Basilea Pharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Basilea Pharmaceutica Correlation With Market
Significant diversification
The correlation between Basilea Pharmaceutica AG and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and DJI in the same portfolio, assuming nothing else is changed.
Basilea |
The ability to find closely correlated positions to Basilea Pharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Basilea Pharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Basilea Pharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Basilea Pharmaceutica AG to buy it.
Moving together with Basilea Pink Sheet
| 0.76 | KNTK | Kinetik Holdings | PairCorr |
| 0.71 | GOOD | Gladstone Commercial | PairCorr |
| 0.78 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
| 0.86 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.88 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.74 | WMT | Walmart Aggressive Push | PairCorr |
| 0.68 | T | ATT Inc Aggressive Push | PairCorr |
| 0.72 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.82 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.72 | HPQ | HP Inc | PairCorr |
Moving against Basilea Pink Sheet
| 0.83 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.79 | NVO | Novo Nordisk AS | PairCorr |
| 0.78 | NONOF | Novo Nordisk AS | PairCorr |
| 0.69 | CSLLY | CSL | PairCorr |
| 0.69 | QSAM | Qsam Biosciences | PairCorr |
| 0.61 | CMXHF | CSL Limited | PairCorr |
| 0.41 | MRLWF | Marlowe plc | PairCorr |
| 0.32 | SGEN | Seagen Inc | PairCorr |
| 0.85 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.6 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.59 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.53 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.34 | PG | Procter Gamble | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Basilea Pink Sheet performing well and Basilea Pharmaceutica Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Basilea Pharmaceutica's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| OCUP | 3.18 | (0.79) | 0.00 | (3.04) | 0.00 | 6.10 | 27.18 | |||
| RVPH | 4.80 | 0.55 | 0.04 | (0.35) | 5.82 | 10.71 | 40.06 | |||
| PLX | 3.15 | 1.10 | 0.27 | (1.33) | 2.38 | 10.00 | 20.38 | |||
| EYPT | 3.86 | (0.29) | (0.01) | 0.03 | 4.25 | 8.03 | 40.16 | |||
| SLS | 2.25 | (0.12) | 0.00 | (0.89) | 0.00 | 5.60 | 17.74 | |||
| PRQR | 5.14 | 1.08 | 0.42 | 0.45 | 2.38 | 7.14 | 129.77 | |||
| ALNY | 1.70 | (0.23) | 0.00 | (0.05) | 0.00 | 2.91 | 13.26 | |||
| WVE | 5.81 | 1.54 | 0.47 | 0.56 | 3.11 | 10.86 | 82.93 | |||
| BPMC | 1.83 | (0.14) | (0.04) | 0.01 | 2.57 | 4.90 | 14.28 | |||
| APLS | 2.44 | (0.34) | 0.00 | (0.35) | 0.00 | 4.31 | 15.97 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Basilea Pharmaceutica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Basilea Pharmaceutica Corporate Management
| Lutz Wevelsiep | Head Affairs | Profile | |
| Adesh Kaul | Chief Officer | Profile | |
| Damian Heller | Gen Sec | Profile | |
| Gerrit Hauck | Chief Officer | Profile | |
| David Veitch | Chief Commercial Officer, Member of the Management Committee | Profile | |
| Ursula Eberhardt | Head HR | Profile | |
| Marc MD | Chief Officer | Profile |